17:28 EST Cytokinetics to replace Calix in S&P 400 at open on 3/18
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CYTK:
- Cytokinetics price target lowered to $99 from $103 at Mizuho
- Cytokinetics to Participate in March Investor Conferences
- Calix to replace Cytokinetics in S&P 600 at open on 3/18
- Cytokinetics to replace Calix in S&P 400 at open on 3/18
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)